United States securities and exchange commission logo




                                                                                
                          April 15, 2024

       Steven Tuch
       Chief Financial Officer
       vTv Therapeutics Inc.
       3980 Premier Drive, Suite 310
       High Point, NC 27265

                                                        Re: vTv Therapeutics 
Inc.
                                                            Registration 
Statement on Form S-3
                                                            Filed April 10, 
2024
                                                            File No. 333-278612

       Dear Steven Tuch:

              This is to advise you that we have not reviewed and will not 
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for 
acceleration. We remind you
       that the company and its management are responsible for the accuracy and 
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of 
action by the staff.

                                                        Please contact Daniel 
Crawford at 202-551-7767 with any questions.



                                                                                
                          Sincerely,

                                                                                
                          Division of Corporation Finance
                                                                                
                          Office of Life Sciences
       cc:                                              David Rosenthal, Esq.